6.

TNM分期、治疗方式分层的腺癌、鳞癌病例中位生存状况对比

Survival comparison of between squamous cell carcinoma and adenocarcinoma of the lung by treatment status and stage

	Adenocarcinoma			Squamous cell		Hazard ratio*(95%CI)	P
	n	Median survival (mon, 95%CI)		n	Median survival (mon, 95%CI)
* Squamous cell vs Adenocarcinoma
TNM stage
Ⅰ & Ⅱ	50	57 (44.2-69.8)		21	50 (28.2-71.8)	0.92 (0.5-1.71)	0.789
Ⅲ	59	15 (10.3-19.7)		72	10 (8.7-11.3)	1.76 (1.22-2.54)	0.001
Ⅳ	52	8 (5.7-10.3)		113	9 (6.7-11.3)	1.15 (0.83-1.61)	0.419
Missing/Unknown	70	26 (20.1-31.9)		101	11 (7.4-14.6)	1.88 (1.35-2.6)	0.000
Treatment status
Surgery	137	40 (30.3-49.7)		31	60 (45.8-74.2)	0.83 (0.52-1.3)	0.167
Non-surgery	81	11 (8.6-13.4)		110	9 (6.5-11.5)	1.14 (0.85-1.54)	0.355
Non-treated	13	9 (3.1-14.9)		166	10 (8.2-11.8)	0.96 (0.75-1.23)	0.988